News from tengion, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 14, 2013, 16:05 ET

Tengion Provides Business Update and Reports Second Quarter 2013 Financial Results

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the...

Aug 07, 2013, 08:30 ET

Tengion Announces Promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the promotion of A. Brian Davis to Chief Financial Officer and...

Jul 01, 2013, 14:41 ET

Tengion Announces Transactions Totaling $33.6 Million to Advance its Organ Regeneration Platform™

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the closing of transactions totaling...

Jun 12, 2013, 16:30 ET

Tengion to Participate in Panel Discussion at ISSCR 11th Annual Meeting

Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that Dr. Tim Bertram, the Company's President of Research and...

May 15, 2013, 08:30 ET

Tengion Provides Business Update and Reports First Quarter 2013 Financial Results

Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the first...

Apr 01, 2013, 08:30 ET

Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the acceptance of the Company's Clinical Trial Application...

Mar 18, 2013, 07:30 ET

Tengion Provides Business Update and Reports Fourth Quarter and Full Year 2012 Financial Results

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year...

Mar 12, 2013, 08:30 ET

Tengion to Present at 25th Annual ROTH Conference

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that John L. Miclot, President and Chief Executive Officer of...

Mar 11, 2013, 16:00 ET

Tengion to Host Conference Call to Provide a Business Update and Report Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013

Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday,...

Feb 05, 2013, 08:00 ET

Tengion to Present at the BIO CEO & Investor Conference

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that A. Brian Davis, Chief Financial Officer and Vice...

Jan 30, 2013, 16:30 ET

Tengion Announces Clinical Progress for Neo-Urinary Conduit™ Phase 1 Trial and Regulatory Advance for Neo-Kidney Augment™

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced advances for its two lead programs, the Neo-Urinary...

Dec 21, 2012, 08:15 ET

Tengion Announces Change to Board of Directors

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that Scott D. Flora, President & Chief Executive Officer...

Nov 13, 2012, 07:00 ET

Tengion Provides Business Update and Reports Third Quarter 2012 Financial Results

Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the third quarter ended September 30, 2012...

Nov 08, 2012, 16:30 ET

Tengion Issued Additional Notice of Allowance for U.S. Patent Application Covering Cell-Scaffold Regeneration for its Neo-Urinary Conduit™ Product Candidate

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that the United States Patent and Trademark Office (USPTO)...

Nov 07, 2012, 08:30 ET

Tengion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that John Miclot, President and Chief Executive Officer of...

Nov 05, 2012, 16:30 ET

Tengion Issued Notice of Allowance for U.S. Patent Application Covering Renal Regeneration for its Neo-Kidney Augment™ Product Candidate

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that the United States Patent and Trademark Office (USPTO) has...

Oct 26, 2012, 07:45 ET

Tengion Provides Patient Update on its Neo-Urinary Conduit™ Clinical Program

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that two patients in the Phase 1 clinical trial of the...

Oct 10, 2012, 08:30 ET

Tengion Announces Closing of $15.0 Million of Senior Secured Convertible Notes Due 2015

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced  the closing of its previously announced private...

Oct 03, 2012, 08:00 ET

Tengion Announces Pricing of $15.0 Million of Senior Secured Convertible Notes Due 2015

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced  the pricing of a private placement of $15.0 million...

Sep 10, 2012, 16:42 ET

Tengion Announces Bridge Financing and Clinical Progress for Neo-Urinary Conduit™ Clinical Program

 Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that it has entered into definitive agreements for a one-month...